Skip to main content
Midas Edge

Nutex Health, Inc.

For the period ended Sep 30, 2025. Filed Nov 19, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 19, 2025

NUTX$186.25-4.1%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)

Common Stock · Additional Paid-inCapital · Accumulated Deficit · NoncontrollingInterests · TotalEquity
(In thousands, except share data) · Shares · Amount
Balance at December 31, 20234,511,199$5$470,521$(409,073)$17,652$79,105
Common stock issued for Employee Stock Purchase Plan746—19——19
Common stock issuance444,444—1,541——1,541
Debt conversion to common stock11,824—321——321
Stock-based compensation——49——49
Vesting of Restricted Stock Units1,298—————
Reverse stock split adjustment2,426—————
Distributions————(481)(481)
Net loss———(364)(178)(542)
Balance at March 31, 20244,971,937$5$472,451$(409,437)$16,993$80,012
Common stock received in sale of business(5,060)—(30)——(30)
Common stock issued for Employee Stock Purchase Plan2,061—14——14
Common stock issued for acquisition17,640—156——156
Stock-based compensation——(61)——(61)
Reverse stock split adjustment690—————
Contributions————301301
Distributions————(1,380)(1,380)
Net income (loss)———(364)3,3743,010
Balance at June 30, 20244,987,268$5$472,530$(409,801)$19,288$82,022
Common stock issued for Employee Stock Purchase Plan4,300—25——25
Common stock issued for acquisition47,106—250——250
Stock-based compensation27,035—1,964——1,964
Warrant exercises150,000—3,820——3,820
Contributions——436—224660
Distributions————(1,798)(1,798)
Net income (loss)———(8,788)1,623(7,165)
Balance at September 30, 20245,215,709$5$479,025$(418,589)$19,337$79,778

(Continued)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)

Common Stock · Additional Paid-inCapital · Accumulated Deficit · NoncontrollingInterests · TotalEquity
(In thousands, except share data) · Shares · Amount
Balance at December 31, 20245,511,452$6$489,409$(356,976)$56,094$188,533
Common stock issued for Employee Stock Purchase Plan1,161—40——40
Stock-based compensation422,091—23,252——23,252
Vesting of Restricted Stock Units15,835—————
Distributions————(7,364)(7,364)
Net income———21,21729,58950,806
Balance at March 31, 20255,950,539$6$512,701$(335,759)$78,319$255,267
Common stock issued for Employee Stock Purchase Plan866—65——65
Asset acquisition noncontrolling interest————789789
Debt conversion to common stock17,874—477——477
Stock-based compensation602,798175,304——75,305
Vesting of Restricted Stock Units23,032—————
Contributions——152—90242
Distributions————(11,412)(11,412)
Net income (loss)———(17,697)33,84116,144
Balance at June 30, 20256,595,109$7$588,699$(353,456)$101,627$336,877
Common stock issued for Employee Stock Purchase Plan351—42——42
Common stock issued for acquisition2,102—250——250
Asset acquisition noncontrolling interest————1,2001,200
Stock-based compensation307,700—26,189——26,189
Contributions————7474
Distributions————(23,398)(23,398)
Net income———55,43541,36496,799
Balance at September 30,20256,905,262$7$615,180$(298,021)$120,867$438,033
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.